Next, to verify whether restoring intestinal barrier function can abolish the progression of atherosclerosis in T3SS‐induced ApoE‐/‐ T2D mice, we intervened with butyrate, an intestinal barrier protector. Here, APOE is linked to type 2 diabetes mellitus.